Needham downgraded Cardlytics from Buy to Hold
Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/11/2024 | $4.00 | In-line | Evercore ISI |
| 8/16/2024 | $5.00 | Outperform → Market Perform | Northland Capital |
| 8/15/2024 | $4.00 → $3.50 | Neutral → Underperform | BofA Securities |
| 8/8/2024 | Buy → Hold | Craig Hallum | |
| 8/8/2024 | Buy → Hold | Needham | |
| 8/8/2024 | $18.00 → $5.00 | Buy → Hold | Lake Street |
| 6/20/2024 | $11.00 | Neutral | BofA Securities |
| 6/18/2024 | $14.00 | Outperform | Northland Capital |
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
8-K - Cardlytics, Inc. (0001666071) (Filer)
8-K - Cardlytics, Inc. (0001666071) (Filer)
10-Q - Cardlytics, Inc. (0001666071) (Filer)
Cardlytics Inc. (NASDAQ:CDLX) today announced the appointment of David Evans as its new Chief Financial Officer, effective January 12, 2026. Evans is returning to Cardlytics, having previously held several executive roles including Chief Financial Officer and Chief Administrative Officer. As the returning Chief Financial Officer, Evans will oversee Cardlytics' finance, accounting, and investor relations functions as the company continues to execute against its longer-term growth vision. Evans rejoins Cardlytics after his initial tenure from 2014 to 2020, during which he helped guide the company through its earlier years of growth and a successful IPO in 2018. Evans is a seasoned executive
Cardlytics, Inc. (NASDAQ:CDLX), a commerce media platform, today announced financial results for the third quarter ended September 30, 2025. "In Q3, we've taken decisive action that we believe will reset our business, improve our financial health, and set ourselves on a viable path to return to growth," said Amit Gupta, CEO of Cardlytics. "We are moving forward with sharper focus and discipline, prioritizing initiatives that build on our fundamental strengths and where we believe we can win. Our mandate is clear – continue to deliver for our partners and advertisers, strengthen what differentiates us, and unlock long-term value for our shareholders." Third Quarter 2025 Financial Results
Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the third quarter ending September 30, 2025 will be released on November 5, 2025, after market close. Conference Call Details: When: November 5, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 18219. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' first-party
Evercore ISI initiated coverage of Cardlytics with a rating of In-line and set a new price target of $4.00
Northland Capital downgraded Cardlytics from Outperform to Market Perform and set a new price target of $5.00
BofA Securities downgraded Cardlytics from Neutral to Underperform and set a new price target of $3.50 from $4.00 previously
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
4 - Cardlytics, Inc. (0001666071) (Issuer)
Cardlytics Inc. (NASDAQ:CDLX) today announced the appointment of David Evans as its new Chief Financial Officer, effective January 12, 2026. Evans is returning to Cardlytics, having previously held several executive roles including Chief Financial Officer and Chief Administrative Officer. As the returning Chief Financial Officer, Evans will oversee Cardlytics' finance, accounting, and investor relations functions as the company continues to execute against its longer-term growth vision. Evans rejoins Cardlytics after his initial tenure from 2014 to 2020, during which he helped guide the company through its earlier years of growth and a successful IPO in 2018. Evans is a seasoned executive
Co-founder and CEO of Cardlytics, Greenlight CMO to Provide Decades of Operational and Marketing Expertise to Portfolio Companies as Firm Enters 25th Year of Fintech Investing ATLANTA, April 30, 2025 /PRNewswire/ -- TTV Capital, an early-stage fintech venture capital firm, today announced that Lynne Laube and Rachel Hamilton have joined as venture partners. In these roles, Lynne and Rachel will provide strategic counsel to TTV Capital's portfolio companies based on their decades of experience scaling early-stage fintech companies. Today's news arrives as TTV Capital marks its 25th year of investing from its home base in Atlanta, the center of the fintech ecosystem. "We started investing in
SUNNYVALE, Calif., Oct. 29, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (the "Company" or "23andMe"), a leading human genetics and preventive health company, today announced the appointments of Andre Fernandez, Jim Frankola, and Mark Jensen, three accomplished and experienced executives, as independent members of the Company's Board of Directors (the "Board"), effective on October 28, 2024. Each of Mr. Fernandez, Mr. Frankola, and Mr. Jensen have been appointed to serve as members of the Board's Audit Committee and Compensation Committee, with Mr. Fernandez serving as the Chair of the Audit Committee and Mr. Jensen serving as the Chair of the Compensation Committee. In additio
SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)
SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)
SC 13D/A - Cardlytics, Inc. (0001666071) (Subject)
Cardlytics, Inc. (NASDAQ:CDLX), a commerce media platform, today announced financial results for the third quarter ended September 30, 2025. "In Q3, we've taken decisive action that we believe will reset our business, improve our financial health, and set ourselves on a viable path to return to growth," said Amit Gupta, CEO of Cardlytics. "We are moving forward with sharper focus and discipline, prioritizing initiatives that build on our fundamental strengths and where we believe we can win. Our mandate is clear – continue to deliver for our partners and advertisers, strengthen what differentiates us, and unlock long-term value for our shareholders." Third Quarter 2025 Financial Results
Cardlytics, Inc. (NASDAQ:CDLX) today announced that its financial results for the third quarter ending September 30, 2025 will be released on November 5, 2025, after market close. Conference Call Details: When: November 5, 2025 at 5:00 pm Eastern time / 2:00 pm Pacific time Webcast: Attendees may access the live audio webcast on the Cardlytics Investor Relations website at ir.cardlytics.com, or by registering at this link. Following the call, a replay will be available on the website. Dial-in: Call participants may dial +1 800-549-8228 and use Conference ID: 18219. About Cardlytics Cardlytics (NASDAQ:CDLX) is a commerce media platform, powered by our publishers' first-party
Cardlytics, Inc. (NASDAQ:CDLX), a commerce media platform, today announced financial results for the second quarter ended June 30, 2025. "Building on the progress we've made over the past year, we are navigating headwinds by doubling down on our diversification efforts and reinforcing our unique network capabilities," said Amit Gupta, CEO of Cardlytics. "We believe our strategic shifts will position us for long-term profitable growth and enable us to deliver on the promise to our stakeholders." Second Quarter 2025 Financial Results Revenue was $63.2 million, a decrease of 9% year-over-year compared to $69.6 million in the second quarter of 2024. Billings, a non-GAAP metric, was $1